These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 26514616)

  • 1. Conversion to stem-cell state in response to microenvironmental cues is regulated by balance between epithelial and mesenchymal features in lung cancer cells.
    Andriani F; Bertolini G; Facchinetti F; Baldoli E; Moro M; Casalini P; Caserini R; Milione M; Leone G; Pelosi G; Pastorino U; Sozzi G; Roz L
    Mol Oncol; 2016 Feb; 10(2):253-71. PubMed ID: 26514616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-β1 exposure induces epithelial to mesenchymal transition both in CSCs and non-CSCs of the A549 cell line, leading to an increase of migration ability in the CD133+ A549 cell fraction.
    Tirino V; Camerlingo R; Bifulco K; Irollo E; Montella R; Paino F; Sessa G; Carriero MV; Normanno N; Rocco G; Pirozzi G
    Cell Death Dis; 2013 May; 4(5):e620. PubMed ID: 23640462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microenvironment-Modulated Metastatic CD133+/CXCR4+/EpCAM- Lung Cancer-Initiating Cells Sustain Tumor Dissemination and Correlate with Poor Prognosis.
    Bertolini G; D'Amico L; Moro M; Landoni E; Perego P; Miceli R; Gatti L; Andriani F; Wong D; Caserini R; Tortoreto M; Milione M; Ferracini R; Mariani L; Pastorino U; Roato I; Sozzi G; Roz L
    Cancer Res; 2015 Sep; 75(17):3636-49. PubMed ID: 26141860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel antibody reagents for characterization of drug- and tumor microenvironment-induced changes in epithelial-mesenchymal transition and cancer stem cells.
    Navas T; Pfister TD; Colantonio S; Aziz A; Dieckman L; Saul RG; Kaczmarczyk J; Borgel S; Alcoser SY; Hollingshead MG; Lee YH; Bottaro DP; Hiltke T; Whiteley G; Takebe N; Kinders RJ; Parchment RE; Tomaszewski JE; Doroshow JH
    PLoS One; 2018; 13(6):e0199361. PubMed ID: 29928062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD133/Src axis mediates tumor initiating property and epithelial-mesenchymal transition of head and neck cancer.
    Chen YS; Wu MJ; Huang CY; Lin SC; Chuang TH; Yu CC; Lo JF
    PLoS One; 2011; 6(11):e28053. PubMed ID: 22140506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NF-κB regulates mesenchymal transition for the induction of non-small cell lung cancer initiating cells.
    Kumar M; Allison DF; Baranova NN; Wamsley JJ; Katz AJ; Bekiranov S; Jones DR; Mayo MW
    PLoS One; 2013; 8(7):e68597. PubMed ID: 23935876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of histamine H4 receptors decreases epithelial-to-mesenchymal transition progress by inhibiting transforming growth factor-β1 signalling pathway in non-small cell lung cancer.
    Cai WK; Hu J; Li T; Meng JR; Ma X; Yin SJ; Zhao CH; He GH; Xu GL
    Eur J Cancer; 2014 Apr; 50(6):1195-206. PubMed ID: 24447834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR‑181b‑5p mediates TGF‑β1-induced epithelial-to-mesenchymal transition in non-small cell lung cancer stem-like cells derived from lung adenocarcinoma A549 cells.
    Li X; Han J; Zhu H; Peng L; Chen Z
    Int J Oncol; 2017 Jul; 51(1):158-168. PubMed ID: 28534939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphere culture of murine lung cancer cell lines are enriched with cancer initiating cells.
    Morrison BJ; Steel JC; Morris JC
    PLoS One; 2012; 7(11):e49752. PubMed ID: 23152931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HGF and TGFβ1 differently influenced Wwox regulatory function on Twist program for mesenchymal-epithelial transition in bone metastatic versus parental breast carcinoma cells.
    Bendinelli P; Maroni P; Matteucci E; Desiderio MA
    Mol Cancer; 2015 Jun; 14():112. PubMed ID: 26041563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD133 is a temporary marker of cancer stem cells in small cell lung cancer, but not in non-small cell lung cancer.
    Cui F; Wang J; Chen D; Chen YJ
    Oncol Rep; 2011 Mar; 25(3):701-8. PubMed ID: 21174061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor-derived stem-cells and epithelial mesenchymal transition in squamous cell carcinoma in transplant recipients.
    Verneuil L; Leboeuf C; Bousquet G; Brugiere C; Elbouchtaoui M; Plassa LF; Peraldi MN; Lebbé C; Ratajczak P; Janin A
    Oncotarget; 2015 Dec; 6(39):41497-507. PubMed ID: 26594799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties.
    Leung EL; Fiscus RR; Tung JW; Tin VP; Cheng LC; Sihoe AD; Fink LM; Ma Y; Wong MP
    PLoS One; 2010 Nov; 5(11):e14062. PubMed ID: 21124918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-small cell lung cancer stem/progenitor cells are enriched in multiple distinct phenotypic subpopulations and exhibit plasticity.
    Akunuru S; James Zhai Q; Zheng Y
    Cell Death Dis; 2012 Jul; 3(7):e352. PubMed ID: 22825470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diverse Targets of β-Catenin during the Epithelial-Mesenchymal Transition Define Cancer Stem Cells and Predict Disease Relapse.
    Chang YW; Su YJ; Hsiao M; Wei KC; Lin WH; Liang CL; Chen SC; Lee JL
    Cancer Res; 2015 Aug; 75(16):3398-410. PubMed ID: 26122848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological significance of tumor budding at the invasive front of human colorectal carcinoma cells.
    Yusra ; Semba S; Yokozaki H
    Int J Oncol; 2012 Jul; 41(1):201-10. PubMed ID: 22569829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-6 promotes growth and epithelial-mesenchymal transition of CD133+ cells of non-small cell lung cancer.
    Lee SO; Yang X; Duan S; Tsai Y; Strojny LR; Keng P; Chen Y
    Oncotarget; 2016 Feb; 7(6):6626-38. PubMed ID: 26675547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial to mesenchymal transition by TGFβ-1 induction increases stemness characteristics in primary non small cell lung cancer cell line.
    Pirozzi G; Tirino V; Camerlingo R; Franco R; La Rocca A; Liguori E; Martucci N; Paino F; Normanno N; Rocco G
    PLoS One; 2011; 6(6):e21548. PubMed ID: 21738704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activin upregulation by NF-κB is required to maintain mesenchymal features of cancer stem-like cells in non-small cell lung cancer.
    Wamsley JJ; Kumar M; Allison DF; Clift SH; Holzknecht CM; Szymura SJ; Hoang SA; Xu X; Moskaluk CA; Jones DR; Bekiranov S; Mayo MW
    Cancer Res; 2015 Jan; 75(2):426-35. PubMed ID: 25432175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor Initiation Capacity and Therapy Resistance Are Differential Features of EMT-Related Subpopulations in the NSCLC Cell Line A549.
    Tièche CC; Gao Y; Bührer ED; Hobi N; Berezowska SA; Wyler K; Froment L; Weis S; Peng RW; Bruggmann R; Schär P; Amrein MA; Hall SRR; Dorn P; Kocher G; Riether C; Ochsenbein A; Schmid RA; Marti TM
    Neoplasia; 2019 Feb; 21(2):185-196. PubMed ID: 30591423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.